JPMORGAN CHASE & CO

Holdings History for Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share (CMPX)

Symbol: CMPX on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	-0%	$4,671,975	870,014	-1,129,264	-56%	$5.37	Q4 2025
30 Sep 2025	0%	-0%	$6,997,474	1,999,278	-126,439	-5.9%	$3.50	Q3 2025
30 Jun 2025	0%	-0%	$5,526,865	2,125,717	-59,763	-2.7%	$2.60	Q2 2025
31 Mar 2025	0%	+0%	$4,152,412	2,185,480	+1,913,152	+700%	$1.90	Q1 2025
31 Dec 2024	0%	+0%	$394,875	272,328	+227,864	+512%	$1.45	Q4 2024
30 Sep 2024	0%	0%	$81,814	44,464	-1,419	-3.1%	$1.84	Q3 2024
30 Jun 2024	0%	+0%	$45,883	45,883	+7,530	+20%	$1.00	Q2 2024
31 Mar 2024	0%	-0%	$75,939	38,353	-23,979	-38%	$1.98	Q1 2024
31 Dec 2023	0%	0%	$97,238	62,332	-407	-0.65%	$1.56	Q4 2023
30 Sep 2023	0%	-0%	$123,596	62,739	-8,425	-12%	$1.97	Q3 2023
30 Jun 2023	0%	0%	$226,302	71,164	0		$3.18	Q2 2023
31 Mar 2023		0%	$1,000	407	0		$2.46 ^*	Q1 2023
31 Mar 2022		-0%	$0	0	-23,749	-100%	$6.34	Q1 2022
31 Dec 2021	0%	+0%	$75,000	23,749	+23,749	NEW	$3.16	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.